aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C.

Yuki Yamashita Satoru JoshitaAyumi SugiuraTomoo YamazakiHiroyuki KobayashiShun-Ichi WakabayashiYosuke YamadaSoichiro ShibataHideo KunimotoTakanobu IwadareMakiko MatsumuraChiharu MiyabayashiTaiki OkumuraSachie OzawaYuichi NozawaNatsuko KobayashiMichiharu KomatsuNaoyuki FujimoriHiromi SaitoTakeji Umemura

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)

The aMAP score could have clinical utility for predicting HCC occurrence in HCV patients achieving an SVR.

Keyphrases

risk assessment
end stage renal disease
newly diagnosed
ejection fraction
risk factors
prognostic factors
hiv infected
antiretroviral therapy
human immunodeficiency virus